Matthias Guckenberger

Radiation Oncologist at University Hospital Zurich @Unispital_USZ | Professor at University of Zurich @UZH_ch | @ESTRO_RT President

[Matthias Guckenberger @Mat_Guc]

🚀 Virtual Grand Round in Radiation Oncology

Latest results of the EXTEND trial

🎤 Dr. Chad Tang

Addition of MTD to SoC for Oligometastatic Solid Tumors: Primary Analysis of EXTEND

📅 2. June 2026, 17:00–17:30 CEST
💻 Join us virtually here: https://t.co/8N7ysfum0s

[ESTRO @ESTRO_RT]

Following his 2024–2026 presidency, Matthias Guckenberger reflects on a tenure dedicated to “Strengthening #RadOnc and #ESTRO through Partnership and Innovation.”
🎥 Watch his recap of key outcomes for our stakeholders 👇@Mat_Guc

[Piet Ost @piet_ost]

What a beautiful message at the end of @Mat_Guc presidency at #ESTRO26 passing the torch to @BarbaraJereczek! See you at #ESTRO27 in Milano, 21-25th of May 2027.

[Lauren Henke, MD, MSCI @lauren_henke]

Dear @ESTRO_RT and @Mat_Guc , thank you for letting this crew help you close out another great year! We hope we gave everyone in attendance some food for thought and inspiration for the trip home. And to the Closing Team: mission accomplished. 💫🍾 See you in Milan next year!

[ESTRO @ESTRO_RT]

🎥 In this #ESTRO26 opening interview, Matthias Guckenberger, President of ESTRO, sets the tone for the days ahead in Stockholm. What does “Innovating Radiation Oncology, Together” really mean in practice? Find out in the video. #radonc @oncoalert @vjoncology @Mat_Guc

[Matthias Guckenberger @Mat_Guc]

❓ What is the optimal duration of ADT if combined with EBRT for definitive treatment of prostate cancer

Virtual Grand Rounds in Radiation Oncology

🎙 Speaker: Dr. @NicholasZaorsky

📅 February 4th, 5 - 5.30 pm CET

💻 Join us virtually here: 👇
https://t.co/LnWKWLtxNz

[Matthias Guckenberger @Mat_Guc]

@GiuliaMarvaso84 @drdavidpalma Not missing at all, different study question 😎
The overview shows SoC vs SoC + MDT

[Matthias Guckenberger @Mat_Guc]

@drdavidpalma @adelapoite @piet_ost Thanks for participating and you 💪💪💪 support of the trial

[Matthias Guckenberger @Mat_Guc]

Virtual Grand Rounds in Radiation Oncology

🥊 Battle of the Treatment Fields: Advancing Radiation Therapy for Leptomeningeal Metastasis

📅 Today
Dr. Jonathan Yang

5pm - 5:30pm CEST
Please join virtually here
👇
https://t.co/cL21ebub5O

[ASTRO @ASTRO_org]

ASTRO is deeply disturbed by the inaccurate, inappropriate, and irresponsible NBC News piece on IORT. We feel this story harms care for breast cancer patients & have strongly rebutted it through our Breast Cancer Resource Panel & a letter from ASTRO CEO, Vivek S Kavadi, MD to NBC News.

Read each here:
Breast Resource Panel Statement
https://t.co/KU1jDQJnaf

Letter to NBC News from Dr. Vivek S. Kavadi
https://t.co/FxfoEtGI7R

[arjun sahgal @SahgalArjun]

Important prediction modeling for patients with oligometastatic cancer based on distant metastases velocity (DMV). Great collaboration and proud to contribute our @Sunnybrook data. No doubt that #SBRT is critical to advancing outcomes for these patients. https://t.co/Ib1WK4x3kn

[Piet Ost @piet_ost]

Join us for #ESTRO26 in Stockholm!!!

[Filippo Alongi @alongi_filippo]

Great collaboration between MOMENTUM and Oligocare registries, presenting the preliminary outcomes (of 15 institutions) regarding liver SBRT using MRI or CT guided approach during #ESTRO2025 !

[ESTRO @ESTRO_RT]

🎥 Exclusive interview this morning at #ESTRO25:
We spoke with ESTRO President Prof Matthias Guckenberger about the congress highlights, this year’s theme of partnership, and the future of radiation oncology.
Don’t miss his insights ⬇️
#Radiotherapy #CancerResearch @Mat_Guc

[Advanced Prostate Cancer Consensus Conference @APCCC_Lugano]

Greetings from #ESTRO25 and a wam welcome to #APCCC26 in Lugano 🇨🇭

@Silke_Gillessen @BarbaraJereczek @piet_ost @ZilliThomas @GiulioFrancoli1 @Mat_Guc @VedangMurthy

@OncoAlert 🚨

[Piet Ost @piet_ost]

SBRT + 💊 in oligomets:
🧍‍♂️2294 pts | 🫁, breast, prostate, colorectal
⚠️Grade 3+ AEs: 1.5%
✅ SBRT Safe with systemic tx!
#SBRT #OligoCare #ESTRO25 @EORTC @ESTRO_RT @CiroFranzese1

[Gerry Hanna @gerryhanna]

Outstanding #ESTRO25 plenary talk from Uffer Pascal, an entrepreneur with stage 4 #lungcancer

“What if radiation oncology was a start up”

Highlights the 5’s:

Collaborate
Communicate
Learn from every Customer
Cost Efficiency
Culture

[Shankar Siva @_ShankarSiva]

📢 🚨#lungcancer peeps. Please consider Prof Andrea Bezjak from @UofT for your next IASLC president! A very deserving candidate and a great representative for #radonc!!! @ldawsonmd #lcsm

[EORTC @EORTC]

🎉We’re excited to announce that the first patient has been randomised in the SPRINT study!

The patient was enrolled at Inselspital in Bern, under the supervision of PI Professor Hossein Hemmatazad.

👉 https://t.co/xNvywtyRts

#E2RADIatE #OligoCare @piet_ost @Mat_Guc

[ESTRO @ESTRO_RT]

🏅 Interview with Dirk Verellen, recipient of the Emmanuel van der Schueren Award at #ESTRO25: Don’t miss his award lecture in Vienna!
📆 Saturday 3 May | 14:15 - 14:40 CEST | Plenary Hall
👉 Full interview here: https://t.co/EAMN05tJdI
#Radonc #OncologyInnovation #ESTROAwards